AVDL vs ECL · rev $169.1M vs P/E 35, rev $4.01B
Avadel Pharmaceuticals PLC (AVDL) versus Ecolab Inc (ECL) — a side-by-side from cached financials, not a winner call.
Avadel Pharmaceuticals PLC (AVDL) is a drug manufacturers - specialty & generic company listed on US.
Ecolab Inc (ECL) is a specialty chemicals company listed on US.
Latest reported AVDL revenue for 2024-12-31 was $169.1M. Net income was -$48.8M. Revenue was up 504.8% from 2023-12-31 to 2024-12-31. AVDL currently screens at market cap $968.5M.
Latest reported ECL revenue for 2024-12-31 was $4.01B. Net income was $2.13B. Revenue was up 0.2% from 2024-09-30 to 2024-12-31. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
AVDL currently screens at market cap $968.5M. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
Not investment advice. Open the AVDL and ECL stock pages for the full models.
Not investment advice.